Cargando…

Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock

The extracorporeal membrane oxygenation (ECMO) procedure aids in the provision of prolonged cardiopulmonary support, whereas the Impella device (Abiomed, Danvers, MA) is a ventricular assist device that maintains circulation by pumping blood into the aorta from the left ventricle. Blood is circulate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vora, Neel, Chaudhary, Rajvi, Upadhyay, Hetarth Vivek, Konat, Ashwati, Zalavadia, Parit, Padaniya, Arif, Patel, Parth, Patel, Nihar, Prajjwal, Priyadarshi, Sharma, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiac/Thoracic/Vascular Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898582/ https://www.ncbi.nlm.nih.gov/pubmed/36751242 http://dx.doi.org/10.7759/cureus.33372

Ejemplares similares

Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021)

Pseudoaneurysm Formation After “Preclose”-Assisted Impella Insertion in a Patient With Cardiogenic Shock
por: Asemota, Daniel, et al.
Publicado: (2022)

Recurrent Stress-Induced Cardiomyopathy With Cardiogenic Shock Requiring Impella Left Ventricular Assist Device
por: Feghaly, Julien, et al.
Publicado: (2021)

Impella-Assisted Intracoronary Lithotripsy of Severely Calcified Left Main Coronary Artery Bifurcation for NSTEMI With Cardiogenic Shock
por: Agrawal, Yashwant, et al.
Publicado: (2021)

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom
por: Faldu, Priyansh, et al.
Publicado: (2022)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock
por: Madjarov, Jeko M., et al.
Publicado: (2021)

Rationale and Design of JenaMACS—Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock
por: Haertel, Franz, et al.
Publicado: (2022)

Prolonged circulatory support with an Impella assist device in the management of cardiogenic shock associated with takotsubo syndrome, severe sepsis and acute respiratory distress syndrome
por: Foley, Edward D, et al.
Publicado: (2017)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

FOLFOX Induced Takotsubo Cardiomyopathy Treated with Impella Assist Device
por: Sundaravel, Swethika, et al.
Publicado: (2017)

Use of impella for off pump myocardial revascularization in high risk patients
por: Pepino, Paolo, et al.
Publicado: (2015)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Cardiogenic shock in thyroid storm: A biventricular impella (Bi‐Pella) approach
por: Caruso, Evan, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Subclinical Aortic Insufficiency Causing Cardiogenic Shock Years After Impella Placement
por: Syed, Ali, et al.
Publicado: (2023)

Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery
por: Sicouri, Serge, et al.
Publicado: (2023)

Is Neutrophil-to-Lymphocyte Ratio a Predictor of Coronary Artery Disease in Western Indians?
por: Sharma, Kamal, et al.
Publicado: (2017)

Cardiac arrest complicating cardiogenic shock: from pathophysiological insights to Impella-assisted cardiopulmonary resuscitation in a pheochromocytoma-induced Takotsubo cardiomyopathy—a case report
por: Zilio, Filippo, et al.
Publicado: (2021)

Defining the optimal revascularization strategy during protected high-risk procedures with Impella
por: Sinning, Jan-Malte, et al.
Publicado: (2022)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Use of Extracorporeal Membrane Oxygenation and Impella as Bridge to Surgery Through Imaging for Cardiogenic Shock
por: Anastasius, Malcolm, et al.
Publicado: (2022)

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
por: Saito, Yuichi, et al.
Publicado: (2023)

Short‐term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device
por: Haddad, Osama, et al.
Publicado: (2023)

Prevalence of Traditional Risk Factors in First-Degree Relatives of Patients With Established Cardiovascular Disease
por: Prajapati, Poojan J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_490m8onk2fbgnui8dkh11c8v5g